madecassic acid has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chu, Y; Dai, Y; Fang, Y; Lv, C; Wei, Z; Xia, Y; Yun, X; Zhang, Q; Zhu, Y | 1 |
1 other study(ies) available for madecassic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells.
Topics: Animals; Azoxymethane; Colitis; Colitis-Associated Neoplasms; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Interleukin-17; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Receptors, Antigen, T-Cell, gamma-delta; Signal Transduction; Th17 Cells; Triterpenes; Tumor Microenvironment | 2022 |